Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs

12 Oct 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Virus Infections Studies
Share to RNA Interference and Gene Delivery
Share to SARS-CoV-2 and COVID-19 Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 34757287
DOI: 10.1016/j.dmpk.2021.100424

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugsPMID 34757287Read ↗

Lipid nanoparticles in the development of mRNA vaccines for COVID-19Semantic proximity Read ↗

Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imagingSemantic proximity Read ↗

Lipid Nanoparticle Delivery Systems to Enable mRNA-Based TherapeuticsSemantic proximity Read ↗

A comprehensive update of siRNA delivery design strategies for targeted and effective gene silencing in gene therapy and other applicationsSemantic proximity Read ↗

Formulation and Evaluation of Bivalent Swine and Avian Lipid Nanoparticles mRNA VaccineSemantic proximity Read ↗

Future considerations for the mRNA-lipid nanoparticle vaccine platformSemantic proximity Read ↗

Potential of siRNA in COVID-19 therapy: Emphasis on in silico design and nanoparticles based deliverySemantic proximity Read ↗

mRNA Vaccine Platforms and Lipid Nanoparticle Delivery Systems: Molecular Advances, Clinical Breakthroughs, and Regulatory Perspectives (2020–2025)Semantic proximity Read ↗

Modular lipid nanoparticle platform technology for siRNA and lipophilic prodrug deliverySemantic proximity Read ↗

Fabrication of mRNA encapsulated Lipid nanoparticles using <i>State-of-the-art</i> SMART-MaGIC Technology and transfection <i>in vitro</i>Semantic proximity Read ↗

Emerging Horizons in Lipid Based Drug Delivery Systems and Nanocarrier TherapeuticsSemantic proximity Read ↗

Significance and applications of nanoparticles in siRNA delivery for cancer therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.